Rating upgraded from 62 to 71 Monday — a welcome improvement, but still below the 80 or higher score you look for.Please ...

Lowe’s Companies stock reached a notable milestone, hitting a 52-week high at 275.22 USD. The stock is currently trading at 275.68 USD, with an impressive 10.98% return just in the past week. This ...

Barclays raised its rating on Lowe's to overweight. The stock could benefit from an improving housing market this year. 10 ...

If you are wondering whether Lowe's Companies stock is offering fair value at around US$247.12, you are not alone. This article is built to help you frame that question clearly. The share price has ...

Lowe's Companies is rated Hold with a $266 price target, reflecting a 9% upside and market-like returns over the next 12 months. Lowe's recent double-beat quarter showed resumed top-line growth and ...

Lowe’s (NYSE: LOW) reported mixed results and tepid guidance, but it was enough to spark a price rebound and signal a buying opportunity for investors. While tepid, the results and outlook affirm ...

Explore the exciting world of Lowe's (NYSE: LOW) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends ...

Baird analyst Ben Kallo upgraded Albemarle Corp (NYSE: ALB) from Neutral to Outperform and raised the price target from $113 ...

Home Depot is trading at a forward 12-month price-to-earnings (P/E) ratio of 23.63, below its one-year median of 24.01.

This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in free cash flow and $10 billion profits over the training 12 months alone. So, ...